Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria.
Affiliation
Department of Diabetes, Galway University Hospital, Galway, Ireland.Issue Date
2012-01-31T16:35:24ZMeSH
AdultDiabetes, Gestational/*diagnosis/*epidemiology/physiopathology
Female
Humans
Infant, Newborn
Pregnancy
Pregnancy Outcome
Metadata
Show full item recordCitation
Diabetologia. 2011 Jul;54(7):1670-5. Epub 2011 Apr 15.Journal
DiabetologiaDOI
10.1007/s00125-011-2150-4PubMed ID
21494772Abstract
AIMS/HYPOTHESIS: New diagnostic criteria for gestational diabetes mellitus (GDM) have recently been published. We wished to evaluate what impact these new criteria would have on GDM prevalence and outcomes in a predominantly European population. METHODS: The Atlantic Diabetes In Pregnancy (DIP) programme performed screening for GDM in 5,500 women with an oral glucose tolerance test at 24-28 weeks. GDM was defined according to the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria and compared with previous WHO criteria; maternal and neonatal adverse outcomes were prospectively recorded. RESULTS: Of the participants, 12.4% and 9.4% were diagnosed with GDM using IADPSG and WHO criteria, respectively. IADPSG GDM pregnancies were associated with a statistically significant increased incidence of adverse maternal outcomes (gestational hypertension, polyhydramnios and Caesarean section) and neonatal outcomes (prematurity, large for gestational age, neonatal unit admission, neonatal hypoglycaemia and respiratory distress). The odds ratio for the development of these adverse outcomes remained significant after adjustment for maternal age, body mass index and non-European ethnicity. Those women who were classified as having normal glucose tolerance by WHO criteria but as having GDM by IADPSG criteria also had significant adverse pregnancy outcomes. CONCLUSIONS/INTERPRETATION: GDM prevalence is higher when using newer IADPSG, compared with WHO, criteria, and these women and their offspring experience significant adverse pregnancy outcomes. Higher rates of GDM pose a challenge to healthcare systems, but improved screening provides an opportunity to attempt to reduce the associated morbidity for mother and child.Language
engISSN
1432-0428 (Electronic)0012-186X (Linking)
ae974a485f413a2113503eed53cd6c53
10.1007/s00125-011-2150-4
Scopus Count
Collections
Related articles
- The World Health Organization (WHO) versus The International Association of Diabetes and Pregnancy Study Group (IADPSG) diagnostic criteria of gestational diabetes mellitus (GDM) and their associated maternal and neonatal outcomes.
- Authors: Basri NI, Mahdy ZA, Ahmad S, Abdul Karim AK, Shan LP, Abdul Manaf MR, Ismail NAM
- Issue date: 2018 Feb 17
- Comparison of criteria of International Association of Diabetes and Pregnancy Study Groups (IADPSG) with National Institute for Health and Care Excellence (NICE) for diagnosis of gestational diabetes mellitus.
- Authors: Todi S, Sagili H, Kamalanathan SK
- Issue date: 2020 Jul
- Pregnancy Outcomes of Women Additionally Diagnosed as Gestational Diabetes by the International Association of the Diabetes and Pregnancy Study Groups Criteria.
- Authors: Kim MH, Kwak SH, Kim SH, Hong JS, Chung HR, Choi SH, Kim MY, Jang HC
- Issue date: 2019 Dec
- Impact of the new IADPSG gestational diabetes diagnostic criteria on pregnancy outcomes in Western Australia.
- Authors: Laafira A, White SW, Griffin CJ, Graham D
- Issue date: 2016 Feb
- Have pregnancy outcomes improved with the introduction of the International Association of Diabetes and Pregnancy Study Groups criteria in Japan?
- Authors: Nakanishi S, Aoki S, Kasai J, Shindo R, Saigusa Y, Miyagi E
- Issue date: 2020 Jul